{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:47:56Z","timestamp":1740134876408,"version":"3.37.3"},"reference-count":10,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,11]]},"DOI":"10.1182\/blood.2024024878","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T15:34:52Z","timestamp":1720712092000},"page":"134-135","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Paving the way to factor X deficiency therapies"],"prefix":"10.1182","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5487-852X","authenticated-orcid":false,"given":"Jeremy P.","family":"Wood","sequence":"first","affiliation":[{"name":"University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"2","key":"2024071115311021400_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1182\/blood.2023023404","article-title":"Fitusiran reduces bleeding in factor X\u2013deficient mice","volume":"144","author":"Verhenne","year":"2024","journal-title":"Blood"},{"key":"2024071115311021400_bib2","doi-asserted-by":"crossref","first-page":"100833","DOI":"10.1016\/j.blre.2021.100833","article-title":"Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency","volume":"50","author":"Peyvandi","year":"2021","journal-title":"Blood Rev"},{"issue":"3","key":"2024071115311021400_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jtha.2022.12.029","article-title":"Hemophilia treatment innovation: 50 years of progress and more to come","volume":"21","author":"Mannucci","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2024071115311021400_bib4","doi-asserted-by":"crossref","first-page":"e28934","DOI":"10.1002\/pbc.28934","article-title":"Novel\u00a0treatments for hemophilia through\u00a0rebalancing of the coagulation cascade","volume":"68","author":"Zhao","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2024071115311021400_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"issue":"2","key":"2024071115311021400_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0037-1613783","article-title":"Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice","volume":"83","author":"Dewerchin","year":"2000","journal-title":"Thromb Haemost"},{"issue":"2","key":"2024071115311021400_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1538-7836.2008.02849.x","article-title":"A\u00a0viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X","volume":"6","author":"Tai","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"22","key":"2024071115311021400_bib8","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.2023021864","article-title":"Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA\/CFC prophylaxis (ATLAS-PPX)","volume":"143","author":"Kenet","year":"2024","journal-title":"Blood"},{"issue":"19","key":"2024071115311021400_bib9","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood-2013-11-512764","article-title":"Biology of tissue factor pathway inhibitor","volume":"123","author":"Wood","year":"2014","journal-title":"Blood"},{"issue":"15","key":"2024071115311021400_bib10","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1016\/j.febslet.2005.03.001","article-title":"The anticoagulant protein C pathway","volume":"579","author":"Dahlback","year":"2005","journal-title":"FEBS Lett"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/2\/134\/2234024\/blood_bld-2024-024878-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/2\/134\/2234024\/blood_bld-2024-024878-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T23:08:21Z","timestamp":1732403301000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/144\/2\/134\/516818\/Paving-the-way-to-factor-X-deficiency-therapies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,7,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024024878","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2024,7,11]]}}}